annual CFO:
-$158.56M-$17.35M(-12.28%)Summary
- As of today (May 29, 2025), NAMS annual cash flow from operations is -$158.56 million, with the most recent change of -$17.35 million (-12.28%) on December 31, 2024.
- During the last 3 years, NAMS annual CFO has fallen by -$129.05 million (-437.29%).
- NAMS annual CFO is now -1586.77% below its all-time high of $10.66 million, reached on December 31, 2022.
Performance
NAMS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$36.47M+$1.01M(+2.70%)Summary
- As of today (May 29, 2025), NAMS quarterly cash flow from operations is -$36.47 million, with the most recent change of +$1.01 million (+2.70%) on March 31, 2025.
- Over the past year, NAMS quarterly CFO has increased by +$18.13 million (+33.21%).
- NAMS quarterly CFO is now -191.70% below its all-time high of -$12.50 million, reached on September 30, 2024.
Performance
NAMS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$140.43M+$18.13M(+11.44%)Summary
- As of today (May 29, 2025), NAMS TTM cash flow from operations is -$140.43 million, with the most recent change of +$18.13 million (+11.44%) on March 31, 2025.
- Over the past year, NAMS TTM CFO has increased by +$23.53 million (+14.35%).
- NAMS TTM CFO is now -340.73% below its all-time high of -$31.86 million, reached on March 31, 2023.
Performance
NAMS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NAMS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.3% | +33.2% | +14.3% |
| 3 y3 years | -437.3% | - | - |
| 5 y5 years | -2059.4% | - | - |
NAMS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1586.8% | at low | -191.7% | +33.2% | -340.7% | +25.6% |
| 5 y | 5-year | -1586.8% | at low | -191.7% | +33.2% | -340.7% | +25.6% |
| alltime | all time | -1586.8% | at low | -191.7% | +33.2% | -340.7% | +25.6% |
NAMS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$36.47M(-2.7%) | -$140.43M(-11.4%) |
| Dec 2024 | -$158.56M(+12.3%) | -$37.48M(+199.8%) | -$158.56M(+2.9%) |
| Sep 2024 | - | -$12.50M(-76.8%) | -$154.16M(-18.3%) |
| Jun 2024 | - | -$53.98M(-1.1%) | -$188.63M(+15.0%) |
| Mar 2024 | - | -$54.60M(+65.1%) | -$163.96M(+16.1%) |
| Dec 2023 | -$141.22M | -$33.07M(-29.6%) | -$141.22M(+30.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$46.98M(+60.3%) | -$108.14M(+76.8%) |
| Jun 2023 | - | -$29.30M(-8.0%) | -$61.17M(+92.0%) |
| Mar 2023 | - | -$31.86M | -$31.86M |
| Dec 2022 | $10.66M(-136.1%) | - | - |
| Dec 2021 | -$29.51M(+301.9%) | - | - |
| Dec 2020 | -$7.34M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual cash flow from operations?
- What is the all time high annual CFO for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual CFO year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly cash flow from operations?
- What is the all time high quarterly CFO for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly CFO year-on-year change?
- What is NewAmsterdam Pharma Company NV TTM cash flow from operations?
- What is the all time high TTM CFO for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV TTM CFO year-on-year change?
What is NewAmsterdam Pharma Company NV annual cash flow from operations?
The current annual CFO of NAMS is -$158.56M
What is the all time high annual CFO for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual cash flow from operations is $10.66M
What is NewAmsterdam Pharma Company NV annual CFO year-on-year change?
Over the past year, NAMS annual cash flow from operations has changed by -$17.35M (-12.28%)
What is NewAmsterdam Pharma Company NV quarterly cash flow from operations?
The current quarterly CFO of NAMS is -$36.47M
What is the all time high quarterly CFO for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly cash flow from operations is -$12.50M
What is NewAmsterdam Pharma Company NV quarterly CFO year-on-year change?
Over the past year, NAMS quarterly cash flow from operations has changed by +$18.13M (+33.21%)
What is NewAmsterdam Pharma Company NV TTM cash flow from operations?
The current TTM CFO of NAMS is -$140.43M
What is the all time high TTM CFO for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high TTM cash flow from operations is -$31.86M
What is NewAmsterdam Pharma Company NV TTM CFO year-on-year change?
Over the past year, NAMS TTM cash flow from operations has changed by +$23.53M (+14.35%)